Spalding J W, Momma J, Elwell M R, Tennant R W
Laboratory of Experimental Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.
Carcinogenesis. 1993 Jul;14(7):1335-41. doi: 10.1093/carcin/14.7.1335.
A transgenic mouse line (TG.AC) created in the FVB/N strain, carries a v-Ha-ras gene fused to a zeta-globin promoter gene. These trangenic mice have the properties of genetically initiated skin and have been shown to be sensitive to 12-O-tetradecanoylphorbol-13-acetate (TPA), a well-described promoter of skin papillomas in the two-stage mouse skin tumorigenesis model. It was of interest to determine whether the TG.AC mouse strain was also responsive to other known promoters. Groups of heterozygous or homozygous TG.AC mice were treated topically, 2x/week, for up to 20 weeks with benzoyl peroxide (BPO), 2-butanol peroxide (2-BUP), phenol (PH), acetic acid (AA), TPA and acetone (ACN), the vehicle control. Skin papillomas were induced in all groups treated with TPA, BPO and 2-BUP. Papillomas were observed in some treatment groups as early as 3 weeks. The relative activity of the promoters was TPA > 2-BUP > BPO > PH = AA = ACN. No papillomas were observed in any of the uninitiated FVB/N mice treated in a similar manner and which served as treatment control groups. Studies to determine the sensitivity of TG.AC mice to TPA, indicated that a total dose of 25-30 micrograms of TPA administered in 3 or 10 applications, was sufficient to induce an average incidence of 11-15 papillomas per mouse. The papilloma incidence continued to increase and was maintained up to 15 weeks after TPA treatment was terminated. The short latency period and high incidence of papilloma induction indicate that TG.AC mice have a high sensitivity to known skin promoters. The TG.AC line should prove to be a sensitive model for identifying putative tumor promoters or complete carcinogens.
在FVB/N品系中培育出的转基因小鼠系(TG.AC),携带一个与ζ-珠蛋白启动子基因融合的v-Ha-ras基因。这些转基因小鼠具有遗传性引发皮肤肿瘤的特性,并且已证明对12-O-十四烷酰佛波醇-13-乙酸酯(TPA)敏感,TPA是两阶段小鼠皮肤肿瘤发生模型中一种广为人知的皮肤乳头瘤启动剂。确定TG.AC小鼠品系是否也对其他已知启动剂有反应很有意义。将杂合或纯合的TG.AC小鼠分组,每周局部给药2次,持续20周,分别给予过氧化苯甲酰(BPO)、2-丁醇过氧化物(2-BUP)、苯酚(PH)、乙酸(AA)、TPA和作为溶剂对照的丙酮(ACN)。用TPA、BPO和2-BUP处理的所有组均诱导出皮肤乳头瘤。在一些处理组中,早在3周时就观察到了乳头瘤。启动剂的相对活性为TPA > 2-BUP > BPO > PH = AA = ACN。以类似方式处理的未引发肿瘤的FVB/N小鼠作为处理对照组,在任何一组中均未观察到乳头瘤。确定TG.AC小鼠对TPA敏感性的研究表明,分3次或10次给药,总剂量为25 - 30微克的TPA足以诱导每只小鼠平均发生11 - 15个乳头瘤。TPA处理终止后,乳头瘤发生率持续上升并维持至15周。乳头瘤诱导的潜伏期短且发生率高,表明TG.AC小鼠对已知的皮肤启动剂高度敏感。TG.AC品系应被证明是一种用于鉴定潜在肿瘤启动剂或完全致癌物的敏感模型。